Iovance Biotherapeutics (NASDAQ:IOVA) stock is taking a beating on Friday after the biotechnology company announced its earnings for the second quarter of the year. Iovance Biotherapeutics starts that report with adjusted earnings per share of -34 cents. That's just barely above the -35 cents per share Wall Street was expecting. It's also better than the -47 cents per share from the same period of the year prior. Revenue reported by Iovance Biotherapeutics also came in at $31.11 million. That's another beat ...